Enhanced chlorhexidine skin penetration with eucalyptus oil

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Karpanen, Tarja J ^a,b   Conway, Barbara R ^a,c   Worthington, Tony ^a   Hilton, Anthony C ^a   Elliott, Tom S J ^b   Lambert, Peter A ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; CHLORHEXIDINE GLUCONATE; EUCALYPTUS OIL; CHLORHEXIDINE; DRUG CARRIER; DRUG DERIVATIVE; ESSENTIAL OIL; EUCALYPTUS TERPENE OIL; TERPENE; TOPICAL ANTIINFECTIVE AGENT;

ANTIMICROBIAL ACTIVITY; ANTISEPSIS; ARTICLE; CONTROLLED STUDY; DERMIS; EPIDERMIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; SKIN PENETRATION; SKINFOLD THICKNESS; EUCALYPTUS; METABOLISM; SKIN; TOPICAL DRUG ADMINISTRATION;

2-PROPANOL; ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; DRUG CARRIERS; EUCALYPTUS; HUMANS; MONOTERPENES; OILS, VOLATILE; SKIN;

EID: 77956792733     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-278     Document Type: Article

References (37)

1. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999, 12(1):147-179. 88911, 9880479.
2. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA. Penetration of chlorhexidine into human skin. Antimicrob Agents Chemother 2008, 52:3633-3636. 10.1128/AAC.00637-08, 2565868, 18676882.
3. Karpanen TJ, Worthington T, Conway BR, Hilton AC, Elliott TS, Lambert PA. Permeation of chlorhexidine from alcoholic and aqueous solutions within excised human skin. Antimicrob Agents Chemother 2009, 53(4):1717-1719. 10.1128/AAC.01289-08, 2663124, 19164143.
4. Hendley JO, Ashe KM. Effect of Topical Antimicrobial Treatment on Aerobic Bacteria in the Stratum Corneum of Human Skin. Antimicrobial Agents and Chemotherapy 1991, 35(4):627-631. 245070, 2069368.
5. Hendley JO, Ashe KM. Eradication of Resident Bacteria of Normal Human Skin by Antimicrobial Ointment. Antimicrobial Agents and Chemotherapy 2003, 47(6):1988-1990. 10.1128/AAC.47.6.1988-1990.2003, 155852, 12760881.
6. Lafforgue C, Carret L, Falson F, Reverdy ME, Freney J. Percutaneous absorption of a chlorhexidine digluconate solution. International Journal of Pharmaceutics 1997, 147:243-246.
7. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. Journal of Infectious Disease 1989, 160(4):644-650.
8. Elsner P. Antimicrobials and the skin physiological and pathological flora. Curr Probl Dermatol 2006, 33:35-41. full_text, 16766879.
9. Leeming JP, Holland KT, Cunliffe WJ. The microbial ecology of pilosebaceous units isolated from human skin. Journal of General Microbiology 1984, 130(4):803-807.
10. Nielsen ML, Raahave D, Stage JG, Justesen T. Anaerobic and aerobic skin bacteria before and after skin-disinfection with chlorhexidine: an experimental study in volunteers. J Clin Pathol 1975, 28(10):793-797. 10.1136/jcp.28.10.793, 475862, 1214012.
11. Elliott TSJ, Moss HA, Tebbs SE, Wilson IC, Bonser RS, Graham TR, Burke LP, Faroqui MH. Novel approach to investigate a source of microbial contamination of central venous catheters. European Journal of Clinical Microbiology and Infectious Diseases 1997, 16(3):210-213.
12. Smyth ET, McIlvenny G, Enstone JE, Emmerson AM, Humphreys H, Fitzpatrick F, Davies E, Newcombe RG, Spencer RC. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect 2008, 69(3):230-248. 10.1016/j.jhin.2008.04.020, 18550218.
13. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discovery Today 2007, 12(23-24):1061-1067. 10.1016/j.drudis.2007.09.001, 18061886.
14. Biruss B, Kahliq H, Valenta C. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones. International Journal of Pharmaceutics 2007, 328:142-151. 10.1016/j.ijpharm.2006.08.003, 16950579.
15. Femenia-Font A, Balaguer-Fernandez C, Merino V, Rodilla V, Lopez-Castellano A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. European Journal of Pharmaceutics and Biopharmaceutics 2005, 61:50-55. 10.1016/j.ejpb.2005.02.014, 15925502.
16. Narishetty STK, Panchagnula R. Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release 2005, 102:59-70. 10.1016/j.jconrel.2004.09.016, 15653134.
17. Yamane MA, Williams AC, Barry BW. Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. International Journal of Pharmaceutics 1995, 116:237-251.
18. Cal K, Janicki S, Sznitowska M. In vitro studies on penetration of terpenes from matrix-type transdermal systems through human skin. International Journal of Pharmaceutics 2001, 224(1-2):81-88. 10.1016/S0378-5173(01)00744-X, 11472817.
19. Cornwell PA, Barry BW, Bouwstra JA, Gooris GS. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. International Journal of Pharmaceutics 1996, 127:9-26.
20. Anjos JL, Neto Dde S, Alonso A. Effects of 1,8-cineole on the dynamics of lipids and proteins of stratum corneum. Int J Pharm 2007, 345(1-2):81-87. 10.1016/j.ijpharm.2007.05.041, 17600646.
21. Gao S, Singh J. Meachanism of trandermal transport of 5-fluorouracil by terpenes: carvone, 1,8-cineole and thymol. Int J Pharm 1997, 154:67-77.
22. Williams AC, Edwards HGM, Lawson EE, Barry BW. Molecular interactions between the penetration enhancer 1,8-cineole and human skin. Journal of Raman Spectroscopy 2006, 37:361-366.
23. Sherry E, Sivananthan S, Warnke PH, Eslick GD. Topical phytochemicals used to salvage the gangrenous lower limbs of type 1 diabetic patients. Diabetes Research and Clinical Practice 2003, 62(1):65-66. 10.1016/j.diabres.2003.07.001, 14581161.
24. Warnke PH, Becker ST, Podschun R, Sivananthan S, Springer IN, Russo PA, Wiltfang J, Fickenscher H, Sherry E. The battle against multi-resistant strains: Renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections. J Craniomaxillofac Surg 2009, 37(7):392-397.
25. Warnke PH, Sherry E, Russo PAJ, Acil Y, Wiltfang J, Sivananthan S, Sprengel M, Roldan JC, Schubert S, Bredee JP, Springer ING. Antibacterial essential oils in malodorous cancer patients: Clinical observations in 30 patients. Phytomedicine 2006, 13(7):463-467. 10.1016/j.phymed.2005.09.012, 16785038.
26. Karpanen TJ, Worthington T, Hendry ER, Conway BR, Lambert PA. Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis. J Antimicrob Chemother 2008, 62(5):1031-1036. 10.1093/jac/dkn325, 18703525.
27. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, McDougall C, Wilcox MH. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007, 65(Suppl 1):S1-64. 10.1016/S0195-6701(07)60002-4, 17307562.
28. Adams D, Quayum M, Worthington T, Lambert P, Elliott T. Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect 2005, 61(4):287-290. 10.1016/j.jhin.2005.05.015, 16221509.
29. Hibbard JS, Mulberry GK, Brady AR. A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine. J Infus Nurs 2002, 25(4):244-249. 10.1097/00129804-200207000-00007, 12131506.
30. Valles J, Fernandez I, Alcaraz D, Chacon E, Cazorla A, Canals M, Mariscal D, Fontanals D, Moron A. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infect Control Hosp Epidemiol 2008, 29(9):847-853. 10.1086/590259, 18665819.
31. Adams DH. An evaluation of three strategies to reduce device related infections associated with hypodermic needles and peripheral vascular catheters. 2006, Birmingham: Aston University.
32. Amini T. Chemical and physical methods of enhancing the percutaneous absorption of antimicrobial agents. 2001, Birmingham: Aston University.
33. dos Anjos JL, de Sousa Neto D, Alonso A. Effects of ethanol/l-menthol on the dynamics and partitioning of spin-labeled lipids in the stratum corneum. Eur J Pharm Biopharm 2007, 67(2):406-412. 10.1016/j.ejpb.2007.02.004, 17350812.
34. Van der Merwe D, Riviere JE. Comparative studies on the effects of water, ethanol and water/ethanol mixtures on chemical partitioning into porcine stratum corneum and silastic membrane. Toxicol In Vitro 2005, 19(1):69-77. 10.1016/j.tiv.2004.06.002, 15582358.
35. Obata Y, Takayama K, Machida Y, Nagai T. Combined effect of cyclic monoterpenes and ethanol on percutaneous absorption of diclofenac sodium. Drug Des Discov 1991, 8(2):137-144.
36. Wang JC, Williams RR, Wang L, Loder J. In vitro skin permeation and bioassay of chlorhexidine phosphanilate, a new antimicrobial agent. Pharm Res 1990, 7(10):995-1002. 10.1023/A:1015978714186, 2281046.
37. Cal K, Kupiec K, Sznitowska M. Effect of physicochemical properties of cyclic terpenes on their ex vivo skin absorption and elimination kinetics. Journal of Dermatological Science 2006, 41(2):137-142. 10.1016/j.jdermsci.2005.09.003, 16260121.